Skip to main content
FEEDBACK PLC logo

FEEDBACK PLC — Investor Relations & Filings

Ticker · FDBK ISIN · GB00BJN59X09 LEI · 213800UGOF2GT2U2RV90 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2018-10-22 Regulatory Filings
Country GB United Kingdom
Listing IL FDBK

About FEEDBACK PLC

https://fbkmed.com/

Feedback PLC is a medical technology company specializing in clinical infrastructure software designed to improve healthcare communication and workflows. Its flagship product, Bleepa®, is a secure digital platform that enables asynchronous collaboration among clinicians. Bleepa provides a unified, patient-centric view of clinical data, including diagnostic-quality medical imaging, test results, and case notes. The platform facilitates secure messaging and virtual discussions for individuals and multi-disciplinary teams (MDTs), allowing for faster decision-making and streamlined referral pathways. By enabling remote and asynchronous case reviews, Bleepa aims to improve care coordination, reduce outpatient appointment requirements, and shorten patient treatment times across public and private healthcare settings.

Recent filings

Filing Released Lang Actions
Expansion of European customer base
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated October 22, 2018. It announces new business orders for the company's product, TexRAD®, across several European hospitals. The text concludes with contact information and a standard disclaimer stating, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure is characteristic of a general regulatory announcement disseminated via the London Stock Exchange's RNS system, rather than a comprehensive financial report (like 10-K or IR) or a specific event material (like AGM-R or CT). Since it is a general regulatory announcement that doesn't fit the more specific categories (like DIRS, DIV, CAP, etc.), the appropriate fallback category is Regulatory Filings (RNS). The document length (4693 chars) is moderate, but the content is purely an announcement of business activity, not the full report itself.
2018-10-22 English
Trading update
Earnings Release Classification · 1% confidence The document begins with an 'RNS Number' and explicitly states that the information is deemed inside information and published via 'Regulatory Information Service'. It provides a 'Trading update' covering financial performance for the year ended May 31, 2018, and the subsequent quarter, including sales figures, operating loss, and strategic updates (board changes, US market strategy). This structure—a brief update on recent performance and strategy released via an official regulatory news service—is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it contains specific financial highlights and performance metrics for a defined period, it fits the definition of an Earnings Release (ER) better than a generic RNS, although it is distributed via RNS. It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), as it is explicitly titled a 'Trading update' and focuses on highlights and commercial progress rather than full statutory accounts. Given the content is a performance update, ER is the most appropriate specific code. The document length (7753 chars) is substantial enough to be more than just a brief announcement of a report (RPA). FY 2018
2018-10-03 English
Appointment of Joint Broker
Board/Management Information Classification · 1% confidence The document is very short (2551 characters) and begins with an 'RNS Number', indicating it is a regulatory news service announcement from the London Stock Exchange. The core content announces the 'Appointment of Joint Broker' (Stanford Capital Partners Limited). This type of announcement, which details a change in corporate advisory/brokerage relationships, is a specific corporate action update. While it could potentially fall under the general 'RNS' category, the appointment of a broker is a significant corporate event announcement that doesn't fit neatly into the other specific categories like ER, 10-K, or DIV. Given the options, 'RNS' (Regulatory Filings) serves as the best general category for miscellaneous, time-sensitive regulatory news releases that aren't covered by more specific codes like DIRS or MANG, although it is a specific corporate announcement. Since there is no specific code for 'Broker Appointment', RNS is the most appropriate fallback for a standard LSE regulatory news release.
2018-10-01 English
TexRAD® ordered by Samsung Medical Centre in Seoul
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated September 10, 2018. The content announces a specific business event: an order for the TexRAD® technology received by Feedback plc via its South Korean distributor. The structure, use of 'ENDS', contact information for PR/IR, and the final section explicitly mentioning 'RNS, the news service of the London Stock Exchange' strongly indicate this is a regulatory news service announcement. Since it is a general business update that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is the general regulatory announcement category, RNS.
2018-09-10 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is explicitly labeled with an 'RNS Number' and contains details about a transaction involving a Director/PDMR (Person Discharging Managerial Responsibilities) selling shares. This type of insider transaction disclosure is specifically covered by the 'Director's Dealing' definition. The presence of the RNS header and the content structure strongly point to a regulatory filing concerning insider trading, which maps directly to the DIRS code. Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2018-08-17 English
First GE Healthcare order for TexRAD®
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated August 15, 2018. It announces a specific business event: receiving the first order via GE Healthcare for their TexRAD® software. The text concludes with standard boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and the FCA. This structure is characteristic of a general regulatory news service announcement, which is not covered by more specific categories like ER, 10-K, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (4736 chars) is moderate, but the content is a direct announcement of a business development rather than a formal report or a mere announcement of a report's publication.
2018-08-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.